Cancer
Breast cancer in Beijing
北京 乳腺癌
20 hospitals in Beijing
Order: papers led on breast cancer, 2021–2025, then A–Z. Research activity, not a rating of care.
Only hospitals listed for breast cancer: those with enough papers or registered trials on it in the records this site uses. Other hospitals in Beijing may also treat it. “Papers led” counts English-language PubMed papers whose first or last author lists the hospital first.
- 333 papers led
- 116 papers led
- 106 papers led
- 91 papers led
- 44 papers led
- 44 papers led
- 40 papers led
- 28 papers ledNo open trial led
- 28 papers led
- 25 papers ledNo open trial led
- 21 papers ledNo open trial led
- 21 papers ledNo open trial led
- 20 papers ledNo open trial led
- 14 papers ledNo open trial led
- 12 papers led
- 12 papers ledNo open trial led
- 4 papers ledNo open trial led
- 1 paper ledNo open trial led
- 0 papers led
- 0 papers ledNo open trial led
Breast cancer in every city Beijing on the disease page, with the national map
open trials on breast cancer with a hospital in Beijing
Recruiting, not yet recruiting, or by invitation, as registered on ClinicalTrials.gov on 18 Nov 2026, with a listed hospital in Beijing as lead sponsor or study site. 95 of them are led by a hospital in Beijing. Check the registry for the current status. Whether someone can take part is decided by the study team.
Only trials registered on ClinicalTrials.gov are counted. Trials registered only in China’s own registry (ChiCTR) are not.
- RecruitingReal-world Study of SKB264 Monotherapy or Combination Therapy in Recurrent or Metastatic HER2-negative Breast Cancer
- Phase
- Not given
- Started
- 2026-05
- Posted
- Registry
- NCT06993506
Age 18 years to Not stated (registered criteria)
Led by National Cancer Center / Cancer Hospital, CAMS; 12 listed hospitals as study sitesBeijing, Changchun, Fuzhou, Hefei, Shanghai, Shijiazhuang, Wuhan, Xiamen, Yantai, Zhengzhou
- RecruitingThe Application of 18F-G1 PET/CT Targeting Granzyme B in the Pan-cancer Immunotherapy
- Phase
- Not given
- Started
- 2026-09
- Posted
- Registry
- NCT07039474
Age 18 years to 75 years (registered criteria)
Led by Peking University First HospitalBeijing
- RecruitingHypofractionated vs Conventional RT After Prosthetic Breast Reconstruction
- Phase
- Phase 3
- Started
- 2026-03
- Posted
- Registry
- NCT07084519
Age 18 years to 75 years; women only (registered criteria)
Led by National Cancer Center / Cancer Hospital, CAMSBeijing
- RecruitingThe Efficacy and Safety of Trastuzumab Rezetecan (SHR-A1811) in HER2-Low Unresectable/Metastatic Breast Cancer Patients With Visceral Crisis
- Phase
- Phase 2
- Started
- 2026-03
- Posted
- Registry
- NCT07203729
Age 18 years to 75 years; women only (registered criteria)
Led by National Cancer Center / Cancer Hospital, CAMSBeijing
- RecruitingA Study of MR001 in Patients With Locally Recurrent or Metastatic Advanced Triple-Negative Breast Cancer (TNBC)
- Phase
- Phase 1/Phase 2
- Started
- 2026-01
- Posted
- Registry
- NCT07208149
Age 18 years to 75 years (registered criteria)
Lead sponsor is not a listed hospital; 3 listed hospitals as study sitesBeijing, Changsha, Wuhan
- RecruitingA Cohort Study of Combined Cryoablation and Thermal Ablation for Non-surgical Treatment of Breast Cancer Patients
- Phase
- N/A
- Started
- 2026-03
- Posted
- Registry
- NCT07238894
Age 18 years to 80 years; women only (registered criteria)
Led by Peking University People's HospitalBeijing
- RecruitingA Study to Evaluate HLX22 in Combination With HLX87 in Patients With HER2-Positive Recurrent or Metastatic Breast Cancer
- Phase
- Phase 2/Phase 3
- Started
- 2026-02
- Posted
- Registry
- NCT07294508
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 1 listed hospital as study siteBeijing
- RecruitingA Study to Evaluate the Effectiveness and Safety of Inavolisib in Participants With Endocrine-resistant, PIK3CA-mutated, Hormone Receptor-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer
- Phase
- Not given
- Started
- 2026-01
- Posted
- Registry
- NCT07347600
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 27 listed hospitals as study sitesBeijing, Changchun, Chengdu, Chongqing, Guangzhou, Guiyang, Haikou, Harbin, Hefei, Jinan, Nanchang, Nanjing, Shanghai, Shenyang, Shijiazhuang, Taiyuan, Taizhou, Weifang, Wuhan, Xi'an, Xiamen, Yangzhou, Zhengzhou
- RecruitingA Study to Evluate Efficacy and Safety of HRS-8080 Combined With Dalpiciclib in Patients With Advanced or Metastatic Breast Cancer Resistant to Adjuvant Endocrine Therapy.
- Phase
- Phase 3
- Started
- 2026-05
- Posted
- Registry
- NCT07354022
Age 18 years to 75 years; women only (registered criteria)
Lead sponsor is not a listed hospital; 1 listed hospital as study siteBeijing
- RecruitingCDK4/6 Inhibitors Combined With Endocrine Therapy for Neoadjuvant Treatment
- Phase
- Phase 2
- Started
- 2026-04
- Posted
- Registry
- NCT07366112
Age 18 years to 75 years; women only (registered criteria)
Led by Peking University People's HospitalBeijing
- RecruitingResponse-Based Local Therapy for Regionally Advanced Breast Cancer
- Phase
- Phase 2
- Started
- 2026-02
- Posted
- Registry
- NCT07376538
Age 18 years to 75 years; women only (registered criteria)
Led by National Cancer Center / Cancer Hospital, CAMSBeijing
- RecruitingRO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or Metastatic Breast Cancer That is Human Epidermal Growth Factor Receptor 2 (HER2)-Positive
- Phase
- Phase 2/Phase 3
- Started
- 2026-05
- Posted
- Registry
- NCT07413939
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 22 listed hospitals as study sitesBeijing, Bengbu, Changsha, Chengdu, Fuzhou, Guangzhou, Hangzhou, Hefei, Jinan, Kunming, Nanjing, Nanning, Shanghai, Shantou, Tianjin, Urumqi, Wuhan
- RecruitingAblation Compare With Surgery for Early Breast Cancer
- Phase
- N/A
- Started
- 2026-01
- Posted
- Registry
- NCT07484087
Age 50 years to Not stated; women only (registered criteria)
Led by Peking University People's HospitalBeijing
- RecruitingBGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease
- Phase
- Phase 3
- Started
- 2026-05
- Posted
- Registry
- NCT07492641
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 28 listed hospitals as study sitesBeijing, Bengbu, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Haikou, Hangzhou, Harbin, Hefei, Kunming, Nanchang, Nanjing, Nanning, Nantong, Shanghai, Shantou, Shijiazhuang, Tianjin, Weifang, Wenzhou, Wuhan, Xi'an, Zhengzhou
- RecruitingA Trial of Trastuzumab Rezetecan in Unresectable Locally Recurrent/Metastatic Breast Cancer
- Phase
- Phase 2
- Started
- 2026-04
- Posted
- Registry
- NCT07497386
Age 18 years to 75 years; women only (registered criteria)
Lead sponsor is not a listed hospital; 1 listed hospital as study siteBeijing
- RecruitingEfficacy and Safety of Tinengotinib Tablets Combined With Fulvestrant Injection in Patients With HR Positive and HER-2 Negative Recurrent or Metastatic Breast Cancer Who Have Failed Prior Treatment
- Phase
- Phase 2
- Started
- 2026-03
- Posted
- Registry
- NCT07498478
Age 18 years to Not stated; women only (registered criteria)
Lead sponsor is not a listed hospital; 13 listed hospitals as study sitesBeijing, Changsha, Chongqing, Guangzhou, Hangzhou, Jinan, Linyi, Nanjing, Shanghai, Tianjin, Wuhan
- RecruitingConstruction of a Benchmark for Breast Ultrasound AI Interpretation and Performance Evaluation of Multimodal AI Models
- Phase
- Not given
- Started
- 2026-03
- Posted
- Registry
- NCT07500428
Age 18 years to 75 years; women only (registered criteria)
Led by Peking Union Medical College HospitalBeijing
- Recruiting18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors
- Phase
- N/A
- Started
- 2026-04
- Posted
- Registry
- NCT07557225
Age 18 years to Not stated (registered criteria)
Led by Peking University First HospitalBeijing
- RecruitingReal-world Study of Pyrotinib-containing Regimens of Advanced HER2-positive Breast Cancer
- Phase
- Phase 4
- Started
- 2026-07
- Posted
- Registry
- NCT07600164
Age 18 years to Not stated (registered criteria)
Led by Peking University People's HospitalBeijing
- RecruitingA Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Unresectable Locally Advanced, Recurrent, or Metastatic HR+/HER2- Breast Cancer After Failure of Prior Endocrine Therapy(PANKU-Breast03)
- Phase
- Phase 3
- Started
- 2026-07
- Posted
- Registry
- NCT07648914
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 1 listed hospital as study siteBeijing
- RecruitingA Study Comparing BL-M07D1 With DS-8201 in Patients With HR-Positive, HER2-Low Expressing Recurrent/Metastatic Breast Cancer
- Phase
- Phase 2
- Started
- 2026-08
- Posted
- Registry
- NCT07678957
Age 18 years to 75 years; women only (registered criteria)
Lead sponsor is not a listed hospital; 1 listed hospital as study siteBeijing
- RecruitingSMP-656 for HER2-Positive Advanced Breast Cancer
- Phase
- Phase 2
- Started
- 2026-08
- Posted
- Registry
- NCT07726342
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 15 listed hospitals as study sitesBeijing, Changsha, Chengdu, Guangzhou, Hangzhou, Hefei, Jinan, Nanjing, Shenyang, Shijiazhuang, Wuhan, Xi'an, Zhengzhou
- RecruitingGB268 Monotherapy or Combination Therapy for Locally Advanced/Metastatic Breast Cancer (Phase Ib/Ⅱ)
- Phase
- Phase 1/Phase 2
- Started
- 2026-07
- Posted
- Registry
- NCT07738341
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 1 listed hospital as study siteBeijing
- RecruitingA Study of SI-B036 in Patients With Locally Advanced or Metastatic Breast Cancer and Other Solid Tumors
- Phase
- Phase 1
- Started
- 2026-08
- Posted
- Registry
- NCT07753226
Age 18 years to 75 years (registered criteria)
Lead sponsor is not a listed hospital; 1 listed hospital as study siteBeijing
- Recruiting68Ga-SorB PET/CT Imaging in Patients With Solid Tumors
- Phase
- N/A
- Started
- 2026-08
- Posted
- Registry
- NCT07760012
Age 18 years to Not stated (registered criteria)
Led by Peking University Third HospitalBeijing
- RecruitingEstablishment of a Multi-omics Prediction Model for Early Triple-negative Breast Cancer Based on UPGRADE-TNBC Study
- Phase
- Not given
- Started
- 2026-08
- Posted
- Registry
- NCT07773818
Age 18 years to 75 years; women only (registered criteria)
Led by National Cancer Center / Cancer Hospital, CAMSBeijing
- RecruitingClinical Investigator-Initiated Trial (IIT) of PD-L1-Targeted Radionuclide Probes
- Phase
- Phase 2
- Started
- 2026-02
- Posted
- Registry
- NCT07848243
Age 18 years to Not stated (registered criteria)
Led by Peking University Cancer HospitalBeijing
- RecruitingA Clinical Study to Evaluate the Efficacy and Safety of JS212 Monotherapy or Combination Therapy in Recurrent or Metastatic Triple-negative Breast Cancer(TNBC)
- Phase
- Phase 2
- Started
- 2026-10
- Posted
- Registry
- NCT07876557
Age 18 years to 70 years (registered criteria)
Lead sponsor is not a listed hospital; 25 listed hospitals as study sitesBeijing, Changchun, Changsha, Chengdu, Fuzhou, Guangzhou, Guiyang, Harbin, Jinan, Lanzhou, Nanchang, Nanjing, Qingdao, Shenyang, Shijiazhuang, Taiyuan, Weifang, Wuhan, Yinchuan, Zhengzhou
- RecruitingNectin-4 Specific LMW PET Probe Imaging in Multiple Solid Tumors
- Phase
- N/A
- Started
- 2025-05
- Posted
- Registry
- NCT05321316
Age 18 years to 75 years (registered criteria)
Led by Peking University Cancer HospitalBeijing
- RecruitingPhase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
- Phase
- Phase 3
- Started
- 2025-07
- Posted
- Registry
- NCT06757634
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 17 listed hospitals as study sitesBeijing, Changsha, Hangzhou, Jinan, Luoyang, Nanchang, Nanjing, Ningbo, Shenyang, Tianjin, Weifang, Xi'an, Xinxiang, Yangzhou, Zhengzhou
- RecruitingAK112 or Placebo Plus Nab-Paclitaxel as First-line Treatment in Inoperable Locally Advanced/ Metastatic Triple-negative Breast Cancer
- Phase
- Phase 3
- Started
- 2025-02
- Posted
- Registry
- NCT06767527
Age 18 years to 75 years (registered criteria)
Lead sponsor is not a listed hospital; 1 listed hospital as study siteBeijing
- RecruitingA Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
- Phase
- Phase 3
- Started
- 2025-04
- Posted
- Registry
- NCT06790693
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 15 listed hospitals as study sitesBeijing, Changsha, Chengdu, Guangzhou, Hangzhou, Harbin, Jinan, Kunming, Nanning, Tianjin, Urumqi, Xi'an, Xiangyang
- RecruitingA Phase IIa Study to Evaluate NBQ72S
- Phase
- Phase 2
- Started
- 2025-04
- Posted
- Registry
- NCT06810804
Age 18 years to Not stated; women only (registered criteria)
Lead sponsor is not a listed hospital; 1 listed hospital as study siteBeijing
- RecruitingA Prospective, Multicenter, Observational Cohort Study to Evaluate the Efficacy and Safety of a Novel Anti-tumor Drug as a Radiosensitizer in Patients With Advanced Breast Cancer Brain Metastasis.
- Phase
- Not given
- Started
- 2025-03
- Posted
- Registry
- NCT06839547
Age 18 years to Not stated (registered criteria)
Led by National Cancer Center / Cancer Hospital, CAMSBeijing
- RecruitingEvaluating the Efficacy and Safety of PD-L1 Monoclonal Antibody Combined With VEX Metronomic Chemotherapy and Concurrent or Delayed Radiotherapy in Patients With Advanced HER2-Negative Breast Cancer With Brain Metastasis
- Phase
- Phase 2
- Started
- 2025-03
- Posted
- Registry
- NCT06839560
Age 18 years to Not stated (registered criteria)
Led by National Cancer Center / Cancer Hospital, CAMSBeijing
- RecruitingEvaluate the Efficacy and Safety of Adebrelimab Combined With Chemotherapy With or Without Radiotherapy as Neoadjuvant Treatment for HER2-Negative Locally Advanced Breast Cancer
- Phase
- Phase 2
- Started
- 2025-03
- Posted
- Registry
- NCT06908668
Age 18 years to 70 years (registered criteria)
Led by National Cancer Center / Cancer Hospital, CAMSBeijing
- RecruitingAl18F-HER2-BCH PET in Breast Patients Treated With ADC Therapy
- Phase
- N/A
- Started
- 2025-01
- Posted
- Registry
- NCT06909604
Age 18 years to Not stated (registered criteria)
Led by Peking University Cancer HospitalBeijing
- RecruitingA Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
- Phase
- Phase 2/Phase 3
- Started
- 2025-09
- Posted
- Registry
- NCT06926868
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 24 listed hospitals as study sitesAnyang, Beijing, Chengdu, Fuzhou, Guangzhou, Hangzhou, Hefei, Jinan, Kunming, Lanzhou, Nanchang, Nanning, Qingdao, Shenyang, Taiyuan, Tianjin, Wuhan, Xiangyang, Zhengzhou
- RecruitingA Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
- Phase
- Phase 3
- Started
- 2025-06
- Posted
- Registry
- NCT06966700
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 21 listed hospitals as study sitesBeijing, Changchun, Changsha, Hangzhou, Harbin, Hefei, Jinan, Nanjing, Nanning, Shanghai, Urumqi, Wuhan, Xi'an, Xiamen, Zhengzhou
- RecruitingctDNA-Guided De-Escalation of Adjuvant Chemotherapy With Dalpiciclib in HR-Positive/HER2-Negative Breast Cancer
- Phase
- Phase 2
- Started
- 2025-08
- Posted
- Registry
- NCT06970912
Age 18 years to 75 years; women only (registered criteria)
Led by Peking University People's HospitalBeijing
- RecruitingSacituzumab Govitecan + Toripalimab as First - Line Therapy for Advanced Triple - Negative Breast Cancer and Biomarker Exploration
- Phase
- Not given
- Started
- 2025-05
- Posted
- Registry
- NCT06991790
Age 18 years to 75 years; women only (registered criteria)
Led by Peking University Cancer HospitalBeijing
- RecruitingGM1 Prophylaxis for Nab-paclitaxel-associated Chemotherapy-induced Peripheral Neuropathy (CIPN) in Patients With Breast Cancer
- Phase
- Phase 3
- Started
- 2025-08
- Posted
- Registry
- NCT06994507
Age 18 years to 75 years; women only (registered criteria)
Lead sponsor is not a listed hospital; 1 listed hospital as study siteBeijing
- RecruitingClinical Trial of TQB2102 for Injection Versus Trastuzumab Emtansine for Injection in HER2-positive Advanced Breast Cancer
- Phase
- Phase 3
- Started
- 2025-07
- Posted
- Registry
- NCT07008976
Age 18 years to 75 years (registered criteria)
Lead sponsor is not a listed hospital; 19 listed hospitals as study sitesAnyang, Beijing, Changchun, Changsha, Fuzhou, Haikou, Hefei, Lanzhou, Linyi, Nanchang, Nanchong, Nanning, Shanghai, Shenyang, Shijiazhuang, Tianjin, Zhengzhou
- RecruitingA Study of Treatment-Related Toxicities and Quality of Life After Local Therapy in Chinese Breast Cancer Patients
- Phase
- Not given
- Started
- 2025-04
- Posted
- Registry
- NCT07010939
Age 18 years to Not stated; women only (registered criteria)
Lead sponsor is not a listed hospital; 3 listed hospitals as study sitesBeijing, Shenzhen, Taiyuan
- RecruitingA Clinical Study of Neoadjuvant Treatment With TQB2102 for Injection for Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer
- Phase
- Phase 3
- Started
- 2025-09
- Posted
- Registry
- NCT07043725
Age 18 years to 75 years (registered criteria)
Lead sponsor is not a listed hospital; 52 listed hospitals as study sitesAnyang, Beijing, Bengbu, Changchun, Changsha, Chengdu, Chongqing, Guangzhou, Guiyang, Harbin, Hefei, Hengyang, Jinan, Lanzhou, Linyi, Luoyang, Luzhou, Meizhou, Nanchang, Nanjing, Nanning, Ningbo, Quanzhou, Shanghai, Shantou, Shenyang, Shijiazhuang, Taiyuan, Taizhou, Tianjin, Urumqi, Weifang, Wenzhou, Wuhan, Xi'an, Xinxiang, Yantai, Zhengzhou
- RecruitingJS207 Combination Therapy in Triple-negative Breast Cancer
- Phase
- Phase 2
- Started
- 2025-09
- Posted
- Registry
- NCT07045311
Age 18 years to 75 years (registered criteria)
Lead sponsor is not a listed hospital; 18 listed hospitals as study sitesBeijing, Changchun, Dalian, Hangzhou, Harbin, Hefei, Nanjing, Qingdao, Shenyang, Shijiazhuang, Urumqi, Wuhan, Xi'an, Zhengzhou
- RecruitingTrop-2 Targeted PET Probes in Advanced TNBC
- Phase
- N/A
- Started
- 2025-03
- Posted
- Registry
- NCT07046455
Age 18 years to 75 years (registered criteria)
Led by Peking University Cancer HospitalBeijing
- RecruitingTQB2930 Injection for the Treatment of HER2-positive Advanced Breast Cancer
- Phase
- Phase 3
- Started
- 2025-07
- Posted
- Registry
- NCT07047365
Age 18 years to 75 years (registered criteria)
Lead sponsor is not a listed hospital; 44 listed hospitals as study sitesAnyang, Beijing, Bengbu, Changchun, Changsha, Chengdu, Chongqing, Guiyang, Haikou, Harbin, Hefei, Jinan, Kunming, Lanzhou, Luoyang, Luzhou, Nanchang, Nanchong, Nanjing, Nanning, Ningbo, Shenyang, Shenzhen, Shijiazhuang, Taiyuan, Tangshan, Tianjin, Weifang, Wenzhou, Xi'an, Xiangyang, Xining, Xinxiang, Xuzhou, Zhengzhou
- RecruitingA Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
- Phase
- Phase 3
- Started
- 2025-07
- Posted
- Registry
- NCT07060807
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 21 listed hospitals as study sitesBeijing, Changchun, Changsha, Chengdu, Chongqing, Guangzhou, Hangzhou, Hefei, Nanchang, Nanjing, Nanning, Taizhou, Urumqi, Xi'an, Xiamen, Xiangyang, Zhengzhou
- RecruitingA Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
- Phase
- Phase 3
- Started
- 2025-08
- Posted
- Registry
- NCT07062965
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 23 listed hospitals as study sitesBeijing, Changchun, Changsha, Dalian, Fuzhou, Guangzhou, Hangzhou, Harbin, Hefei, Jinan, Nanchang, Nanjing, Nanning, Shanghai, Shijiazhuang, Wenzhou, Wuhan, Xi'an
- RecruitingA Study of SKB264 Versus Investigator's Choice of Chemotherapy in Subjects With Unresectable Locally Advanced, Relapsed, or Metastatic HR+/HER2- Breast Cancer Who Have Previously Failed Endocrine Therapy
- Phase
- Phase 3
- Started
- 2025-07
- Posted
- Registry
- NCT07071337
Age 18 years to 75 years (registered criteria)
Lead sponsor is not a listed hospital; 2 listed hospitals as study sitesBeijing, Guangzhou
- RecruitingNeoadjuvant Oral Paclitaxel Plus Subcutaneous Pertuzumab/Trastuzumab in Patients With HER2-positive Breast Cancer
- Phase
- N/A
- Started
- 2025-08
- Posted
- Registry
- NCT07095023
Age 18 years to 75 years (registered criteria)
Led by Sun Yat-sen Memorial Hospital; 5 listed hospitals as study sitesBeijing, Guangzhou, Guiyang, Shantou, Shenzhen, Wenzhou
- RecruitingA Clinical Trial of SHR-A1811 in the Treatment of Triple-negative Breast Cancer
- Phase
- Phase 3
- Started
- 2025-08
- Posted
- Registry
- NCT07111832
Age 18 years to 75 years; women only (registered criteria)
Lead sponsor is not a listed hospital; 2 listed hospitals as study sitesBeijing, Shanghai
- RecruitingA Study of LY4257496 in Participants With Cancer (OMNIRAY)
- Phase
- Phase 1
- Started
- 2025-08
- Posted
- Registry
- NCT07114601
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 2 listed hospitals as study sitesBeijing, Tianjin
- RecruitingExploration of the Safety and Efficacy of T-DXd Concurrent With Brain Radiotherapy in Patients With Brain Metastases HER2-positive/HER2-low Advanced Breast Cancer
- Phase
- N/A
- Started
- 2025-07
- Posted
- Registry
- NCT07117864
Age 18 years to 75 years; women only (registered criteria)
Led by National Cancer Center / Cancer Hospital, CAMSBeijing
- RecruitingA Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
- Phase
- Phase 3
- Started
- 2025-12
- Posted
- Registry
- NCT07174336
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 14 listed hospitals as study sitesAnyang, Beijing, Changchun, Changsha, Chengdu, Fuzhou, Guangzhou, Harbin, Shanghai, Shantou, Tianjin, Wuhan
- RecruitingAn Investigational Study of BG-75202 Alone and in Combination With Other Agents in Adults With Advanced Solid Tumors
- Phase
- Phase 1
- Started
- 2025-12
- Posted
- Registry
- NCT07222267
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 10 listed hospitals as study sitesBeijing, Changsha, Chongqing, Hangzhou, Harbin, Nanjing, Shanghai, Tianjin, Xiamen
- Recruiting68Ga-PFA2 PET Imaging for the Diagnosis of Annexin A2-Positive Tumors
- Phase
- Not given
- Started
- 2025-06
- Posted
- Registry
- NCT07331532
Age 18 years to 80 years (registered criteria)
Led by Peking University First HospitalBeijing
- RecruitingA Bidirectional Cohort Study on Prophylactic Resection Surgery in Populations at Moderate-to-High Risk for Hereditary Ovarian Cancer
- Phase
- Not given
- Started
- 2025-09
- Posted
- Registry
- NCT07532434
Age 18 years to Not stated; women only (registered criteria)
Led by Peking University Third HospitalBeijing
- RecruitingRomiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gynecologic, Breast, or Lung Solid Tumors
- Phase
- Phase 2
- Started
- 2025-12
- Posted
- Registry
- NCT07586826
Age 18 years to Not stated (registered criteria)
Led by Peking University People's HospitalBeijing
- RecruitingA Trial Comparing GQ1005 and T-DM1 in Patients With HER2-Positive Unresectable or Metastatic Breast Cancer
- Phase
- Phase 3
- Started
- 2025-01
- Posted
- Registry
- NCT07673029
Age 18 years to 75 years (registered criteria)
Lead sponsor is not a listed hospital; 51 listed hospitals as study sitesAnyang, Beijing, Bengbu, Changchun, Changsha, Chengdu, Chongqing, Dalian, Fuzhou, Guangzhou, Guiyang, Hangzhou, Harbin, Hefei, Jinan, Kunming, Linyi, Luoyang, Meizhou, Nanchang, Nanning, Qingdao, Quanzhou, Shanghai, Shantou, Shenyang, Shijiazhuang, Taiyuan, Tianjin, Weifang, Wuhan, Xi'an, Xinxiang, Xuzhou, Yantai, Zhengzhou
- RecruitingSafety Assessment of Concurrent Radiotherapy and Novel Systemic Therapy for Breast Cancer
- Phase
- N/A
- Started
- 2024-01
- Posted
- Registry
- NCT06197581
Age 18 years to 70 years; women only (registered criteria)
Led by National Cancer Center / Cancer Hospital, CAMSBeijing
- RecruitingA Study to Assess the Effectiveness of Trastuzumab Deruxtecan in Chinese Breast Cancer Patients (REFRESH)
- Phase
- Not given
- Started
- 2024-01
- Posted
- Registry
- NCT06210776
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 41 listed hospitals as study sitesBeijing, Chengdu, Foshan, Fuzhou, Guangzhou, Hangzhou, Harbin, Hefei, Kunming, Luoyang, Nanchang, Nanjing, Nantong, Qingdao, Shanghai, Shantou, Shenyang, Shenzhen, Taiyuan, Tangshan, Tianjin, Urumqi, Weifang, Xi'an, Xinxiang, Xuzhou, Yinchuan, Zhengzhou, Zhuhai
- RecruitingA Phase III Study of ESG401 for Locally Advanced or Metastatic HR+/HER2- Breast Cancer
- Phase
- Phase 3
- Started
- 2024-07
- Posted
- Registry
- NCT06383767
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 1 listed hospital as study siteBeijing
- RecruitingApplication of 68GA-labeled CD73 Targeting Probe PET/CT Imaging in the Diagnosis of Breast Cancer
- Phase
- Early phase 1
- Started
- 2024-05
- Posted
- Registry
- NCT06411678
Age 18 years to 70 years; women only (registered criteria)
Led by Peking Union Medical College HospitalBeijing
- RecruitingAdebrelimab Plus Apatinib and Etoposide for the Treatment of HER2-Negative Breast Cancer Brain Metastasis
- Phase
- Phase 2
- Started
- 2024-10
- Posted
- Registry
- NCT06418594
Age 18 years to Not stated; women only (registered criteria)
Led by Chinese PLA General HospitalBeijing
- RecruitingStudy of ADCs Combined With Adebrelimab in HER2-negative Advanced Breast Cancer
- Phase
- Phase 2
- Started
- 2024-08
- Posted
- Registry
- NCT06433609
Age 18 years to 75 years (registered criteria)
Led by Beijing GoBroad HospitalBeijing
- RecruitingA Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- Phase
- Phase 1
- Started
- 2024-07
- Posted
- Registry
- NCT06465069
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 3 listed hospitals as study sitesBeijing, Guangzhou, Shanghai
- RecruitingA Phase I Study of XS-02 Capsules in Patients With Advanced Solid Tumors
- Phase
- Phase 1
- Started
- 2024-08
- Posted
- Registry
- NCT06531486
Age 18 years to 75 years (registered criteria)
Lead sponsor is not a listed hospital; 1 listed hospital as study siteBeijing
- RecruitingHypofractionated Online Adaptive Radiotherapy of Breast Cancer
- Phase
- Phase 2
- Started
- 2024-09
- Posted
- Registry
- NCT06568705
Age 35 years to 70 years; women only (registered criteria)
Led by Peking Union Medical College HospitalBeijing
- RecruitingSafety and Efficacy of BA1302 in Patients With Advanced Solid Tumors
- Phase
- Phase 1
- Started
- 2024-09
- Posted
- Registry
- NCT06596915
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 1 listed hospital as study siteBeijing
- RecruitingA Study of GNC-077 in Patients With Locally Advanced or Metastatic Breast Cancer and Other Solid Tumors
- Phase
- Phase 1
- Started
- 2024-10
- Posted
- Registry
- NCT06609187
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 1 listed hospital as study siteBeijing
- RecruitingProspective Validation and Application of an Artificial Intelligence-based Model for Evaluating the Efficacy of Breast Cancer Patients After Neoadjuvant Therapy
- Phase
- Not given
- Started
- 2024-01
- Posted
- Registry
- NCT06649565
Age 18 years to Not stated; women only (registered criteria)
Led by National Cancer Center / Cancer Hospital, CAMSBeijing
- RecruitingLarge Segmentation Radiotherapy ± Deep Inspiration Breath Hold(DIBH) for Left Breast Cancer
- Phase
- N/A
- Started
- 2024-08
- Posted
- Registry
- NCT06660628
Age 18 years to 70 years; women only (registered criteria)
Led by Peking Union Medical College HospitalBeijing
- RecruitingEstablishment and Clinical Transformation of ADC Drug Efficacy Evaluation System for Breast Cancer Based on Molecular Imaging
- Phase
- N/A
- Started
- 2024-12
- Posted
- Registry
- NCT06715020
Age 18 years to 75 years (registered criteria)
Led by Peking University Cancer HospitalBeijing
- RecruitingImpact of Recombinant Humanized Type III Collagen on the Immediate and Long-term Effects of Breast Tumor Surgery
- Phase
- Phase 1
- Started
- 2024-12
- Posted
- Registry
- NCT06725082
Age 18 years to 80 years; women only (registered criteria)
Led by Peking University People's HospitalBeijing
- RecruitingHypofractionated Postoperative Regional Nodal Irradiation for Patients With Intermediate-risk Breast Cancer
- Phase
- Phase 3
- Started
- 2024-10
- Posted
- Registry
- NCT06757621
Age 45 years to Not stated; women only (registered criteria)
Led by National Cancer Center / Cancer Hospital, CAMSBeijing
- RecruitingPhase II Clinical Trial of PD-L1 in Combination With Vinorelbine + Cyclophosphamide + Capecitabine (VEX) Metronomic Chemotherapy With or Without Radiotherapy for Advanced Triple-negative Breast Cancer.
- Phase
- Phase 2
- Started
- 2024-09
- Posted
- Registry
- NCT06771609
Age 18 years to Not stated (registered criteria)
Led by National Cancer Center / Cancer Hospital, CAMSBeijing
- RecruitingA Prospective, Multicenter, Observational Cohort Study Assessing the Efficacy and Safety of Radiotherapy-sensitized Immunotherapy in Advanced Breast Cancer
- Phase
- Not given
- Started
- 2024-09
- Posted
- Registry
- NCT06776861
Age 18 years to Not stated (registered criteria)
Led by National Cancer Center / Cancer Hospital, CAMSBeijing
- RecruitingThe Impact of Intelligent Patient Management Model on Medication Adherence of Pyrotinib Compared to Traditional Patient Management Model: a Prospective, Multicenter, Randomized Controlled Clinical Study
- Phase
- Phase 2/Phase 3
- Started
- 2024-04
- Posted
- Registry
- NCT06958627
Age 18 years to Not stated; women only (registered criteria)
Led by National Cancer Center / Cancer Hospital, CAMSBeijing
- RecruitingEvaluation of Trop-2 ADC in Breast Cancer Patients With Brain Metastases: A Real-World Study
- Phase
- Not given
- Started
- 2024-08
- Posted
- Registry
- NCT07251868
Age 18 years to Not stated (registered criteria)
Led by Peking University Cancer HospitalBeijing
- RecruitingImpact of Erector Spinae Plane Block on Chronic Postsurgical Pain in Breast Cancer Patients
- Phase
- N/A
- Started
- 2023-05
- Posted
- Registry
- NCT05494502
Age 18 years to 85 years (registered criteria)
Led by Peking University First Hospital; 1 listed hospital as study siteBeijing
- RecruitingEvaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
- Phase
- Phase 3
- Started
- 2023-10
- Posted
- Registry
- NCT05696626
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 57 listed hospitals as study sitesAnyang, Beijing, Bengbu, Changchun, Changsha, Chengdu, Chongqing, Dalian, Fuzhou, Guangzhou, Haikou, Hangzhou, Kunming, Lanzhou, Linyi, Luoyang, Luzhou, Meizhou, Nanchang, Nanjing, Nanning, Ningbo, Qingdao, Shanghai, Shenyang, Shenzhen, Shijiazhuang, Tianjin, Urumqi, Wenzhou, Wuhan, Xi'an, Xiamen, Xiangyang, Xuzhou, Zhengzhou
- RecruitingPhase II/III Study of SPH4336 Combined With Letrozole vs Placebo Combined With Letrozole in First-line Treatment of Breast Cancer
- Phase
- Phase 2/Phase 3
- Started
- 2023-04
- Posted
- Registry
- NCT05744687
Age 18 years to 75 years; women only (registered criteria)
Lead sponsor is not a listed hospital; 7 listed hospitals as study sitesAnyang, Beijing, Changchun, Fuzhou, Guangzhou, Luoyang, Yinchuan
- RecruitingSafety and Efficacy of SPH4336 in Combination With Endocrine Therapy in the Treatment of Locally Advanced or Metastatic Breast Cancer
- Phase
- Phase 2/Phase 3
- Started
- 2023-09
- Posted
- Registry
- NCT05860465
Age 18 years to 75 years; women only (registered criteria)
Lead sponsor is not a listed hospital; 17 listed hospitals as study sitesAnyang, Beijing, Bengbu, Changchun, Fuzhou, Guangzhou, Hangzhou, Harbin, Kunming, Luoyang, Nanjing, Shenyang, Shijiazhuang, Tianjin, Xi'an, Yinchuan
- RecruitingEfficacy and Safety of SPH4336 in Combination With Endocrine Therapy in Breast Cancer Patients With Brain Metastases.
- Phase
- Phase 2
- Started
- 2023-09
- Posted
- Registry
- NCT05872347
Age 18 years to 75 years; women only (registered criteria)
Lead sponsor is not a listed hospital; 21 listed hospitals as study sitesAnyang, Beijing, Bengbu, Changchun, Guangzhou, Hangzhou, Harbin, Hefei, Luoyang, Nanjing, Nanning, Shijiazhuang, Tianjin, Urumqi, Wuhan, Xiangyang, Yinchuan, Zhengzhou
- RecruitingEfficacy and Safety of Fluzoparib Combined With Adjuvant Endocrine Therapy for HR+/HER2- SNF3-subtype Early Breast Cancer (BCTOP-L-A01)
- Phase
- Phase 3
- Started
- 2023-06
- Posted
- Registry
- NCT05891093
Age 18 years to 70 years; women only (registered criteria)
Led by Fudan University Shanghai Cancer Center; 13 listed hospitals as study sitesBeijing, Chengdu, Chongqing, Fuzhou, Guangzhou, Nantong, Ningbo, Shanghai, Shenyang, Xi'an, Yangzhou
- RecruitingA Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer
- Phase
- Phase 3
- Started
- 2023-09
- Posted
- Registry
- NCT05894239
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 14 listed hospitals as study sitesBeijing, Changchun, Chengdu, Fuzhou, Hangzhou, Jinan, Luoyang, Nanchang, Nanning, Shijiazhuang, Tianjin, Wuhan
- RecruitingStudy of Antivascular Therapy Combined With Chemotherapy Versus Chemotherapy in Adjuvant Therapy of TNBC-BLIS Patients (BCTOP-T-A03)
- Phase
- Phase 3
- Started
- 2023-06
- Posted
- Registry
- NCT05909332
Age 18 years to 70 years; women only (registered criteria)
Led by Fudan University Shanghai Cancer Center; 13 listed hospitals as study sitesBeijing, Chengdu, Chongqing, Fuzhou, Guangzhou, Nantong, Ningbo, Shanghai, Shenyang, Xi'an, Yangzhou
- RecruitingTrastuzumab Deruxtecan (T-DXd) in Patients Who Have Hormone Receptor-negative and Hormone Receptor-positive HER2-low or HER2 IHC 0 Metastatic Breast Cancer
- Phase
- Phase 3
- Started
- 2023-12
- Posted
- Registry
- NCT05950945
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 13 listed hospitals as study sitesBeijing, Fuzhou, Hangzhou, Hefei, Jinan, Kunming, Nanchang, Qingdao, Shanghai, Xi'an, Zhengzhou
- RecruitingChidamide/Everolimus for PIK3CA Wild-type/Mutant HR+/HER2- Advanced Breast Cancer
- Phase
- Phase 2
- Started
- 2023-07
- Posted
- Registry
- NCT05983107
Age 18 years to 75 years; women only (registered criteria)
Led by National Cancer Center / Cancer Hospital, CAMSBeijing
- RecruitingPyrotinib Plus Capecitabine for Adjuvant Treatment of HER2 Positive Early-stage Breast Cancer
- Phase
- Not given
- Started
- 2023-06
- Posted
- Registry
- NCT06035016
Age 18 years to 75 years; women only (registered criteria)
Led by Peking Union Medical College HospitalBeijing
- RecruitingJSKN003 Versus Treatment Of Physician'S Choice For HER2-low, Unresectable and/or Metastatic Breast Cancer Subjects
- Phase
- Phase 3
- Started
- 2023-12
- Posted
- Registry
- NCT06079983
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 60 listed hospitals as study sitesAnyang, Beijing, Changchun, Changsha, Chengdu, Chongqing, Dalian, Fuzhou, Guangzhou, Guiyang, Hangzhou, Harbin, Hefei, Hengyang, Jinan, Kunming, Lanzhou, Linyi, Luoyang, Meizhou, Nanchang, Nanjing, Qingdao, Shanghai, Shantou, Shenyang, Shijiazhuang, Suzhou, Taiyuan, Tianjin, Urumqi, Wuhan, Xi'an, Xiamen, Xiangyang, Xining, Xinxiang, Xuzhou, Zhanjiang, Zhengzhou, Zunyi
- RecruitingStudy of SKB264 for Locally Advanced, Recurrent or Metastatic HR+/HER2- Breast Cancer
- Phase
- Phase 3
- Started
- 2023-10
- Posted
- Registry
- NCT06081959
Age 18 years to 75 years (registered criteria)
Lead sponsor is not a listed hospital; 1 listed hospital as study siteBeijing
- Recruiting99mTc-MY6349 SPECT/CT Imaging in Trop2-positive Triple-negative Breast Cancer
- Phase
- N/A
- Started
- 2023-09
- Posted
- Registry
- NCT06104085
Age 18 years to 80 years; women only (registered criteria)
Led by Peking Union Medical College HospitalBeijing
- RecruitingA Study of YL202 in Selected Patients With Advanced Solid Tumors
- Phase
- Phase 2
- Started
- 2023-12
- Posted
- Registry
- NCT06107686
Age 18 years to 75 years (registered criteria)
Lead sponsor is not a listed hospital; 45 listed hospitals as study sitesBeijing, Changchun, Changsha, Chengdu, Chongqing, Guangzhou, Guilin, Hangzhou, Harbin, Hefei, Jinan, Meizhou, Nanchang, Nanning, Qingdao, Shanghai, Shantou, Shenyang, Suzhou, Taiyuan, Taizhou, Urumqi, Weifang, Wuhan, Xi'an, Xiangyang, Xuzhou, Zhengzhou
- RecruitingBGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors
- Phase
- Phase 1
- Started
- 2023-12
- Posted
- Registry
- NCT06120283
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 7 listed hospitals as study sitesBeijing, Fuzhou, Guangzhou, Harbin, Nanchang, Shanghai, Shenyang
- RecruitingClinical Study of HRS-8080 in Combination With Dalpiciclib Isethionate Tablets in Patients With Unresectable or Metastatic Breast Cancer
- Phase
- Phase 1/Phase 2
- Started
- 2023-12
- Posted
- Registry
- NCT06167694
Age 18 years to 75 years; women only (registered criteria)
Lead sponsor is not a listed hospital; 2 listed hospitals as study sitesBeijing, Guangzhou
- RecruitingPhotoacoustic/Ultrasound Imaging for Breast Nodule Diagnosis, Molecular Classification, and Neoadjuvant Chemotherapy Response Evaluation
- Phase
- N/A
- Started
- 2023-06
- Posted
- Registry
- NCT06908291
Age 18 years to Not stated; women only (registered criteria)
Led by Peking Union Medical College HospitalBeijing
- RecruitingA Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
- Phase
- Phase 1
- Started
- 2022-10
- Posted
- Registry
- NCT05208762
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 3 listed hospitals as study sitesBeijing, Shanghai
- RecruitingEffectiveness of Cryotherapy Combined With Compression Therapy for Preventing Chemotherapy-induced Peripheral Neuropathy
- Phase
- N/A
- Started
- 2022-06
- Posted
- Registry
- NCT05341141
Age 20 years to 70 years; women only (registered criteria)
Led by Peking University Cancer HospitalBeijing
- RecruitingAdopting the MRD Strategy to Optimize Post-operation Adjuvant Therapies for Early Stage Breast Cancer
- Phase
- N/A
- Started
- 2022-03
- Posted
- Registry
- NCT05345860
Age 18 years to Not stated; women only (registered criteria)
Led by National Cancer Center / Cancer Hospital, CAMSBeijing
- RecruitingJAB-2485 Activity in Adult Patients With Advanced Solid Tumors
- Phase
- Phase 1/Phase 2
- Started
- 2022-12
- Posted
- Registry
- NCT05490472
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 4 listed hospitals as study sitesBeijing, Changchun, Jinan
- Recruiting68Ga-RM26-RGD PET/CT Imaging in the GRPR and αvβ3 Positive Tumor Patients
- Phase
- Early phase 1
- Started
- 2022-08
- Posted
- Registry
- NCT05549024
Age 18 years to Not stated (registered criteria)
Led by Peking Union Medical College HospitalBeijing
- RecruitingFluzoparib Combined With Camrelizumab for Neoadjuvant Treatment of Embryogenic BRCA Mutation HER2 Negative Breast Cancer: an Open, Single Arm, Multicenter Study
- Phase
- Phase 2
- Started
- 2022-10
- Posted
- Registry
- NCT05576389
Age 18 years to Not stated; women only (registered criteria)
Led by Peking University People's HospitalBeijing
- RecruitingRinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
- Phase
- Phase 1/Phase 2
- Started
- 2022-12
- Posted
- Registry
- NCT05579366
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 15 listed hospitals as study sitesBeijing, Changchun, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou, Shanghai, Shenyang, Taiyuan, Tianjin, Wuhan
- RecruitingA Prospective Study of Preoperative Tumor-bed Boost Followed by Oncoplastic Surgery and Adjuvant Whole Breast Radiotherapy for Early Stage Breast Cancer (BIRKIN)
- Phase
- N/A
- Started
- 2022-06
- Posted
- Registry
- NCT05603078
Age Not stated to 55 years; women only (registered criteria)
Led by National Cancer Center / Cancer Hospital, CAMSBeijing
- RecruitingUltra-hypofractioNated Adjuvant Radiotherapy ± sImultaneous Integrated Boost for Low-risk Breast Cancer Patients
- Phase
- Phase 2
- Started
- 2022-10
- Posted
- Registry
- NCT05762900
Age 35 years to Not stated; women only (registered criteria)
Led by National Cancer Center / Cancer Hospital, CAMSBeijing
- RecruitingOptical Surface Monitoring Technology-Guided Large-Segment Radiotherapy for Breast Cancer
- Phase
- Phase 2/Phase 3
- Started
- 2022-04
- Posted
- Registry
- NCT05804916
Age 18 years to 70 years; women only (registered criteria)
Led by Peking Union Medical College HospitalBeijing
- RecruitingComparison Between Prepectoral and Subpectoral Breast Reconstruction
- Phase
- Not given
- Started
- 2022-03
- Posted
- Registry
- NCT05833659
Age 18 years to 70 years; women only (registered criteria)
Led by Beijing Friendship HospitalBeijing
- RecruitingA Phase Ⅲ Study of Hemay022 in Combination With AI In Advanced Breast Cancer
- Phase
- Phase 3
- Started
- 2022-01
- Posted
- Registry
- NCT06313983
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 1 listed hospital as study siteBeijing
- RecruitingSuper-Hypofractionated Partial Breast Irradiation
- Phase
- N/A
- Started
- 2022-04
- Posted
- Registry
- NCT06615466
Age 45 years to 74 years; women only (registered criteria)
Led by National Cancer Center / Cancer Hospital, CAMSBeijing
- RecruitingA Study to Evaluate D-0502 in Subjects With ER+ Her2- Locally Advanced or Metastatic Breast Cancer
- Phase
- Phase 3
- Started
- 2022-09
- Posted
- Registry
- NCT06954961
Age 18 years to 75 years; women only (registered criteria)
Lead sponsor is not a listed hospital; 2 listed hospitals as study sitesBeijing, Harbin
- RecruitingStudy of BEBT-209 in Combination With Fulvestrant Versus Placebo in Combination With Fulvestrant in Patients With HR+/HER2- Locally Advanced or Metastatic Breast Cancer Who Have Progressed After Prior Endocrine Therapy
- Phase
- Phase 3
- Started
- 2022-06
- Posted
- Registry
- NCT06998108
Age 18 years to Not stated; women only (registered criteria)
Lead sponsor is not a listed hospital; 1 listed hospital as study siteBeijing
- RecruitingNeoadjuvant Therapy Study Guided by Drug Screening in Vitro for HER2 Positive Early Breast Cancer Patients
- Phase
- Phase 1/Phase 2
- Started
- 2021-03
- Posted
- Registry
- NCT04750122
Age 18 years to 75 years; women only (registered criteria)
Led by Peking University People's HospitalBeijing
- RecruitingEffect of Huaier Granule on Adjuvant Treatment for High-risk Early-stage Triple-negative Breast Cancer
- Phase
- Phase 4
- Started
- 2021-06
- Posted
- Registry
- NCT04790305
Age 18 years to 70 years (registered criteria)
Led by Fudan University Shanghai Cancer Center; 26 listed hospitals as study sitesBeijing, Changchun, Changsha, Chongqing, Fuzhou, Guangzhou, Hefei, Jinan, Nanjing, Ningbo, Qingdao, Shanghai, Shenyang, Shijiazhuang, Suzhou, Wuhan, Xi'an, Yangzhou, Zhengzhou
- RecruitingNeoadjuvant Therapy Study Guided by Drug Screening in Vitro for Human Epidermal Growth Factor Receptor 2 (HER2) Negative Early Breast Cancer Patients
- Phase
- Phase 1/Phase 2
- Started
- 2021-04
- Posted
- Registry
- NCT04836156
Age 18 years to 75 years; women only (registered criteria)
Led by Peking University People's HospitalBeijing
- RecruitingTrastuzumab Combined With Pyrrolidine and Chemotherapy for Locally HER2 Positive Breast Cancer
- Phase
- Phase 2
- Started
- 2020-07
- Posted
- Registry
- NCT04481932
Age 18 years to 70 years; women only (registered criteria)
Led by Peking University Cancer HospitalBeijing
- RecruitingStudy to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
- Phase
- Phase 2
- Started
- 2020-09
- Posted
- Registry
- NCT04557449
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 5 listed hospitals as study sitesBeijing, Hangzhou, Wuhan, Xi'an, Zhengzhou
- RecruitingStudy of PF-07248144 in Advanced or Metastatic Solid Tumors
- Phase
- Phase 2
- Started
- 2020-11
- Posted
- Registry
- NCT04606446
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 3 listed hospitals as study sitesBeijing, Guangzhou, Xi'an
- RecruitingSelective Omission of Axillary Surgery in Triple-negative and HER2-positive Breast Cancer After NACT
- Phase
- N/A
- Started
- 2020-07
- Posted
- Registry
- NCT05314114
Age 18 years to 70 years; women only (registered criteria)
Led by Peking University Cancer HospitalBeijing
- RecruitingDe-escalation of Neoadjuvant Chemotherapy Regimens With Immunotherapy Among TNBC
- Phase
- Not given
- Started
- 2019-01
- Posted
- Registry
- NCT06692725
Age not stated (registered criteria)
Led by Peking University People's HospitalBeijing
- RecruitingAdjuvant Therapy With Neratinib in HER2 Positive Early Breast Cancer
- Phase
- Not given
- Started
- 2019-01
- Posted
- Registry
- NCT06693024
Age not stated (registered criteria)
Led by Peking University People's HospitalBeijing
- RecruitingAdjuvant Therapy Choice for Non-pCR HER2 Positive Early Breast Cancer After Neoadjuvant Therapy
- Phase
- Not given
- Started
- 2019-01
- Posted
- Registry
- NCT06693037
Age not stated (registered criteria)
Led by Peking University People's HospitalBeijing
- RecruitingDifferent Methods of Capecitabine in Patients With Non-PCR After Neoadjuvant Therapy for TNBC
- Phase
- Not given
- Started
- 2019-01
- Posted
- Registry
- NCT06700382
Age not stated (registered criteria)
Led by Peking University People's HospitalBeijing
- RecruitingAdjuvant Therapy for Intermediate Risk HER2 Positive, Lymph Node Negative Early Breast Cancer With Chemotherapy Combined Target Therapy
- Phase
- Not given
- Started
- 2019-01
- Posted
- Registry
- NCT06711068
Age not stated (registered criteria)
Led by Peking University People's HospitalBeijing
- RecruitingFour Cycles Taxane With Trastuzumab and Pertuzumab Neoadjuvant Therapy Among Low Risk HER2 Positive Patients
- Phase
- Not given
- Started
- 2019-01
- Posted
- Registry
- NCT06722599
Age not stated (registered criteria)
Led by Peking University People's HospitalBeijing
- RecruitingChemotherapy Combined With Targeted Therapy for High-risk HER2 Positive and Lymph Node Negative Early Breast Cancer
- Phase
- Not given
- Started
- 2019-01
- Posted
- Registry
- NCT06722612
Age not stated (registered criteria)
Led by Peking University People's HospitalBeijing
- RecruitingNeoadjuvant Endocrine Therapy Versus Chemotherapy in Premenopausal Patients With ER+ & HER2- Breast Cancer
- Phase
- Phase 3
- Started
- 2015-07
- Posted
- Registry
- NCT02535221
Age 35 years to 55 years; women only (registered criteria)
Led by Peking University Cancer HospitalBeijing
- RecruitingDe-escalation of Neoadjuvant Chemotherapy Regimens With Targeted Therapy Among HER2 Positive Patients
- Phase
- Not given
- Started
- 2015-01
- Posted
- Registry
- NCT06700369
Age not stated (registered criteria)
Led by Peking University People's HospitalBeijing
- RecruitingTaxane Combined Targeted Therapy for Low-risk HER2 Positive and Lymph Node Negative Breast Cancer
- Phase
- Not given
- Started
- 2015-01
- Posted
- Registry
- NCT06711055
Age not stated; women only (registered criteria)
Led by Peking University People's HospitalBeijing
- Not yet recruitingADC Based Therapy Accroding to HER2 Heterogeneous
- Phase
- Phase 2
- Started
- 2027-01
- Posted
- Registry
- NCT07844018
Age 18 years to Not stated; women only (registered criteria)
Led by Peking University People's HospitalBeijing
- Not yet recruitingA Randomized Controlled Trial of Acupuncture for the Management of Hot Flashes in Patients With Hormone Receptor-Positive Breast Cancer
- Phase
- N/A
- Started
- 2026-04
- Posted
- Registry
- NCT07294339
Age 18 years to 75 years; women only (registered criteria)
Led by Peking University People's HospitalBeijing
- Not yet recruitingChemotherapy With or Without Adebrelimab and T-DXh as Neoadjuvant Therapy for HR+/HER2 Low Early Stage Breast Cancer
- Phase
- Phase 2
- Started
- 2026-02
- Posted
- Registry
- NCT07317778
Age 18 years to 75 years; women only (registered criteria)
Led by National Cancer Center / Cancer Hospital, CAMSBeijing
- Not yet recruitingEffect of Esketamine on Perioperative Negative Emotions in Patients Undergoing Breast Cancer Surgery
- Phase
- N/A
- Started
- 2026-01
- Posted
- Registry
- NCT07367542
Age 18 years to Not stated; women only (registered criteria)
Led by Chinese PLA General HospitalBeijing
- Not yet recruitingEfficacy and Safety of Qibei Jiedu Formula for Preventing and Managing Acute Radiation Dermatitis in Breast Cancer Patients
- Phase
- N/A
- Started
- 2026-01
- Posted
- Registry
- NCT07380230
Age 18 years to Not stated; women only (registered criteria)
Led by National Cancer Center / Cancer Hospital, CAMSBeijing
- Not yet recruitingEffect of Transcutaneous Auricular Vagus Nerve Stimulation on Perioperative Negative Emotions in Breast Cancer Surgery Patients
- Phase
- N/A
- Started
- 2026-02
- Posted
- Registry
- NCT07458646
Age 18 years to Not stated (registered criteria)
Led by Chinese PLA General HospitalBeijing
- Not yet recruitingEffect of Acupuncture on Psychoneurological Symptom Cluster in Breast Cancer Survivors
- Phase
- N/A
- Started
- 2026-04
- Posted
- Registry
- NCT07481903
Age 18 years to 75 years; women only (registered criteria)
Led by First Teaching Hospital, Tianjin University of Traditional Chinese Medicine; 3 listed hospitals as study sitesBeijing, Nanjing, Tianjin
- Not yet recruitingA Study of AK138D1 Alone or in Combination With Ivonescimab in Advanced Breast Cancer
- Phase
- Phase 1/Phase 2
- Started
- 2026-06
- Posted
- Registry
- NCT07560124
Age 18 years to 75 years (registered criteria)
Lead sponsor is not a listed hospital; 3 listed hospitals as study sitesBeijing, Chengdu, Harbin
- Not yet recruiting5T4 Targeting Nanobody Probe for PET Imaging in Solid Tumors
- Phase
- N/A
- Started
- 2026-06
- Posted
- Registry
- NCT07589101
Age 18 years to 70 years (registered criteria)
Led by Peking University Cancer HospitalBeijing
- Not yet recruitingClinical Application of Vagus Nerve Stimulation Combined With Immunoregulatory T Cells in Alleviating Aromatase Inhibitor-Induced Pain
- Phase
- N/A
- Started
- 2026-05
- Posted
- Registry
- NCT07593365
Age 18 years to Not stated; women only (registered criteria)
Led by Peking University People's HospitalBeijing
- Not yet recruitingA Phase II Study of GV20-0251 in Combination With Anti-PD-1 Monoclonal Antibodies in Patients With Unresectable, Locally Advanced, or Metastatic Solid Tumors.
- Phase
- Phase 2
- Started
- 2026-06
- Posted
- Registry
- NCT07623642
Age 18 years to 80 years (registered criteria)
Lead sponsor is not a listed hospital; 2 listed hospitals as study sitesBeijing, Harbin
- Not yet recruitingRisk-Stratified Hypofractionated Radiotherapy After Breast-Conserving Surgery for Early Breast Cancer
- Phase
- N/A
- Started
- 2026-06
- Posted
- Registry
- NCT07657442
Age 18 years to 75 years; women only (registered criteria)
Led by National Cancer Center / Cancer Hospital, CAMSBeijing
- Not yet recruitingA Phase II Study of Radiation Therapy to Treat Refractory Breast Cancer
- Phase
- N/A
- Started
- 2026-06
- Posted
- Registry
- NCT07672743
Age 18 years to 75 years; women only (registered criteria)
Led by National Cancer Center / Cancer Hospital, CAMSBeijing
- Not yet recruitingEfficacy and Safety of Utidelone Capsule and Utidelone Injection in Patients With HER-2 Negative Advanced Breast Cancer
- Phase
- Phase 3
- Started
- 2026-08
- Posted
- Registry
- NCT07684456
Age 18 years to 75 years (registered criteria)
Lead sponsor is not a listed hospital; 1 listed hospital as study siteBeijing
- Not yet recruitingA Study of T-DXd in AI-Assessed HER2-Ultralow Metastatic Breast Cancer
- Phase
- N/A
- Started
- 2026-09
- Posted
- Registry
- NCT07782086
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 9 listed hospitals as study sitesBeijing, Chengdu, Hefei, Luzhou, Nanjing, Shanghai, Xi'an, Xuzhou
- Not yet recruitingSLNB Combined With WLNB for Axillary De-escalation in Breast Cancer Patients With Abnormal Axillary Nodes
- Phase
- Not given
- Started
- 2026-07
- Posted
- Registry
- NCT07791771
Age 18 years to Not stated; women only (registered criteria)
Led by Peking University Cancer HospitalBeijing
- Not yet recruitingExploration of Dalpiciclib Plus HDACi in HR+/HER2- Advanced Breast Cancer After Failure of CDK4/6 Inhibitor
- Phase
- Phase 2
- Started
- 2025-10
- Posted
- Registry
- NCT06556862
Age 18 years to Not stated (registered criteria)
Led by Chinese PLA General HospitalBeijing
- Not yet recruitingFamilial Breast Cancer in China
- Phase
- Not given
- Started
- 2025-02
- Posted
- Registry
- NCT06833216
Age 18 years to 75 years; women only (registered criteria)
Led by National Cancer Center / Cancer Hospital, CAMSBeijing
- Not yet recruitingAcupuncture for Anxiety and Depression
- Phase
- N/A
- Started
- 2025-05
- Posted
- Registry
- NCT06994351
Age 18 years to 70 years; women only (registered criteria)
Led by Guang'anmen HospitalBeijing
- Not yet recruitingAcupuncture for Anxiety/Depression in Patients With Breast Cancer
- Phase
- N/A
- Started
- 2025-09
- Posted
- Registry
- NCT07183813
Age 18 years to 70 years; women only (registered criteria)
Led by Guang'anmen HospitalBeijing
- Not yet recruitingTrastuzumab Deruxtecan (T-DXd) With Pyrotinib in First-line HER2-positive Unresectable or Metastatic Breast Cancer Trial
- Phase
- Phase 4
- Started
- 2024-01
- Posted
- Registry
- NCT06245824
Age 18 years to Not stated (registered criteria)
Led by National Cancer Center / Cancer Hospital, CAMSBeijing
- Not yet recruitingA PARG Inhibitor DAT-2645 Monotherapy in Patients with Advanced/Metastatic Solid Tumors Harboring BRCA1/2 Loss of Function Alterations And/or Other Defects in the DDR Pathway
- Phase
- Phase 1
- Started
- 2024-11
- Posted
- Registry
- NCT06614751
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 2 listed hospitals as study sitesBeijing
- Not yet recruitingStudy of Utidelone Based Neoadjuvant Treatment on Early High-risk or Locally Advanced Breast Cancer
- Phase
- Phase 2
- Started
- 2023-09
- Posted
- Registry
- NCT05983094
Age 18 years to 70 years; women only (registered criteria)
Led by National Cancer Center / Cancer Hospital, CAMSBeijing
- Not yet recruitingThe Efficacy and Safety of Dalpiciclib Plus Endocrine Therapy in HR-positive / HER2-negative Advanced Breast Cancer Patients With Visceral Crisis
- Phase
- Phase 2
- Started
- 2022-06
- Posted
- Registry
- NCT05431504
Age 18 years to Not stated; women only (registered criteria)
Led by National Cancer Center / Cancer Hospital, CAMSBeijing
- Not yet recruitingInetetamab Plus Rapamycin and Chemotherapy for HER2+ Metastatic Breast Cancer With Abnormal Activation of PAM Pathway
- Phase
- Phase 3
- Started
- 2021-02
- Posted
- Registry
- NCT04736589
Age 18 years to 85 years; women only (registered criteria)
Led by National Cancer Center / Cancer Hospital, CAMSBeijing
- Not yet recruitingA Prospective Cohort Study Comparing Disparity in Surgical Procedure (Wide Local Excision Only vs Any Other Surgery Procedures) Among the Elderly Breast Cancer Patients
- Phase
- Not given
- Started
- 2020-06
- Posted
- Registry
- NCT04426136
Age 70 years to Not stated; women only (registered criteria)
Led by Peking Union Medical College HospitalBeijing
- Enrolling by invitationExercise Intervention for Breast Cancer Patients With Sarcopenia
- Phase
- N/A
- Started
- 2026-09
- Posted
- Registry
- NCT07732101
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 1 listed hospital as study siteBeijing
- Enrolling by invitationMultigene Risk Score Combined With Ki-67 Dynamic Assessment in Stratified Neoadjuvant Endocrine Therapy Treatment With or Without CDK4/6 Inhibitors in HR+/HER2- Breast Cancer
- Phase
- Phase 2
- Started
- 2025-05
- Posted
- Registry
- NCT06650748
Age 18 years to 70 years; women only (registered criteria)
Led by Peking University Cancer HospitalBeijing
- Enrolling by invitationA Multicenter Prospective Cohort Study of Adjuvant Therapy for BRCA1/2 Mutated Hormone Receptor-positive HER2-negative Early High-risk Breast Cancer
- Phase
- Not given
- Started
- 2025-01
- Posted
- Registry
- NCT06791161
Age 18 years to 75 years; women only (registered criteria)
Led by National Cancer Center / Cancer Hospital, CAMSBeijing
- Enrolling by invitationA Study Comparing the Differences Between Young and Non-young Breast Cancer
- Phase
- Not given
- Started
- 2025-01
- Posted
- Registry
- NCT06793306
Age 18 years to 75 years; women only (registered criteria)
Led by National Cancer Center / Cancer Hospital, CAMSBeijing
- Enrolling by invitationPaclitaxel Polymeric Micelles and Carboplatin in Combination With Iparomilimab and Tuvonralimab Neoadjuvant Therapy for Triple-negative Breast Cancer(UPGRADE-TNBC)
- Phase
- Phase 2/Phase 3
- Started
- 2025-07
- Posted
- Registry
- NCT06910072
Age 18 years to 75 years; women only (registered criteria)
Led by National Cancer Center / Cancer Hospital, CAMSBeijing
- Enrolling by invitationEffect of (neo)Adjuvant Therapy on Lipids in Young Breast Cancer Patients
- Phase
- Not given
- Started
- 2024-05
- Posted
- Registry
- NCT06405269
Age 18 years to 40 years; women only (registered criteria)
Led by National Cancer Center / Cancer Hospital, CAMSBeijing
- Enrolling by invitationIntensive Adjuvant Therapy for TNBC with BRCA Gene Mutation
- Phase
- Not given
- Started
- 2024-05
- Posted
- Registry
- NCT06405295
Age 18 years to 75 years; women only (registered criteria)
Led by National Cancer Center / Cancer Hospital, CAMSBeijing
- Enrolling by invitationSacituzumab Govitecan Plus Bevacizumab in Metastatic TNBC
- Phase
- Phase 2
- Started
- 2024-04
- Posted
- Registry
- NCT07359404
Age 18 years to Not stated; women only (registered criteria)
Led by National Cancer Center / Cancer Hospital, CAMSBeijing
Order: recruiting first, then not yet recruiting and by invitation; newest start first. Not a ranking.
Disease research in Beijing
Each number is papers led on that disease, 2021–2025. “Open” counts open trials the hospital leads. Hospitals A–Z; this is not a ranking.
A blank cell means no papers or trials were found in these records. It does not mean the hospital does not treat that disease.
| Cancer | Blood disorders | Other diseases | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospital | Nasopharyngeal carcinoma | Oesophageal squamous cell carcinoma | Hepatocellular carcinoma | Stomach cancer | Lung cancer | Pancreatic cancer | Breast cancer | Glioma | Hepatoblastoma | Retinoblastoma | Chordoma | Osteosarcoma | Gastrointestinal stromal tumour | Neuroblastoma | Ewing sarcoma | Multiple myeloma | B-cell acute lymphoblastic leukaemia | Aplastic anaemia | Haemophagocytic lymphohistiocytosis | Lymphoma | Beta thalassaemia | Haemophilia A | Atypical haemolytic uraemic syndrome | Thrombotic thrombocytopenic purpura | Fanconi anaemia | Neuromyelitis optica spectrum disorder | IgG4-related disease | Myasthenia gravis | Moyamoya disease | Wilson disease | Biliary atresia | Coronary heart disease | Congenital heart disease | Scoliosis | Anti-NMDA receptor encephalitis | Takayasu arteritis | Hepatic echinococcosis | Idiopathic pulmonary fibrosis | Lymphangioleiomyomatosis | Amyotrophic lateral sclerosis | Spinal muscular atrophy | Fabry disease | Pompe disease | Duchenne muscular dystrophy | Behçet disease | Alport syndrome | IgA nephropathy | Gaucher disease | Niemann–Pick disease type C | Osteogenesis imperfecta | Primary biliary cholangitis | Primary sclerosing cholangitis | Congenital diaphragmatic hernia | Hirschsprung disease | Inherited epidermolysis bullosa | Hereditary angioedema | Familial adenomatous polyposis | Leber hereditary optic neuropathy | Majeed syndrome | NGLY1 deficiency | ISG15 deficiency | Shortlist |
| Aerospace Center Hospital航天中心医院 | none | none | none | none | none | none | none | none | none | none | none | 1 | 1 | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 3 | 3 | 2 | none | 0 | none | none | none | none | none | none | 1 | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Air Force General Hospital中国人民解放军空军特色医学中心 | none | none | none | none | none | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Beijing An Hospital | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 01 open | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Beijing Anding Hospital首都医科大学附属北京安定医院 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Beijing Anzhen Hospital首都医科大学附属北京安贞医院 | none | 6 | none | none | none | none | none | none | none | none | none | 1 | 0 | none | none | none | none | none | 2 | none | 0 | none | none | none | none | none | 0 | none | none | none | none | 19611 open | 805 open | none | none | 30 | none | 1 | none | none | none | 0 | none | none | 2 | 1 | 3 | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | |
| Beijing Army General Hospital中国人民解放军总医院第七医学中心 | none | none | none | none | none | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Beijing Boren Hospital北京高博博仁医院 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 0 | 1 | none | none | 4 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Beijing Chao-Yang Hospital首都医科大学附属北京朝阳医院 | none | 8 | 18 | 12 | 662 open | 18 | 21 | none | none | none | 2 | 6 | 0 | 1 | 2 | 52 | none | none | none | 2 | 0 | none | 0 | 0 | none | none | none | none | none | none | none | 342 open | 3 | 40 | none | 3 | none | 13 | none | 1 | none | none | none | none | 1 | none | 4 | none | none | none | 3 | 2 | 1 | none | none | none | 0 | none | none | none | none | |
| Beijing Chest Hospital首都医科大学附属北京胸科医院 | none | none | none | none | 802 open | none | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Beijing Children's Hospital首都医科大学附属北京儿童医院 | none | none | none | none | none | none | none | none | 4 | 6 | none | 5 | none | 331 open | 4 | none | 4 | 9 | 311 open | 25 | 1 | 33 | 2 | 0 | 1 | 2 | none | none | 2 | none | 15 | 6 | 24 | 17 | 4 | 3 | none | none | none | 1 | 0 | 0 | none | 1 | 1 | 1 | 7 | 0 | none | none | none | none | none | 13 | 1 | none | none | none | 0 | none | none | |
| Beijing Daxing District People's Hospital北京市大兴区人民医院 | none | none | none | none | none | none | none | none | none | none | none | 2 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Beijing Ditan Hospital, Capital Medical University首都医科大学附属北京地坛医院 | none | none | 72 | none | none | none | none | 5 | 0 | none | none | none | none | none | none | none | none | none | none | 7 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 0 | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | 11 | 0 | none | none | none | none | none | none | none | none | none | |
| Beijing Friendship Hospital首都医科大学附属北京友谊医院 | none | 12 | 511 open | 457 open | 38 | 10 | 401 open | none | 1 | 1 | none | 2 | 2 | 47 | 1 | 1 | none | none | 523 open | 30 | none | 0 | none | 0 | none | none | 12 | 1 | none | 41 open | 4 | 251 open | 0 | none | none | 2 | none | 1 | none | none | none | none | 1 | none | 1 | none | 0 | 2 | none | none | 121 open | 4 | none | 0 | none | none | none | none | none | none | none | |
| Beijing Fuwai Hospital | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Beijing GoBroad Hospital北京高博医院 | none | 01 open | 01 open | none | none | none | 01 open | none | none | none | none | none | none | none | none | 02 open | 04 open | none | none | 25 open | none | none | none | none | none | none | 01 open | 01 open | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Beijing Haidian Hospital北京市海淀医院 | none | none | none | none | 02 open | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Beijing Hospital北京医院 | none | none | 151 open | 4 | 74 | 10 | 25 | none | none | none | none | none | 0 | 1 | none | 2 | none | none | none | 6 | none | 2 | none | 0 | none | 0 | none | 11 | 41 open | none | none | 303 open | 3 | none | 0 | 1 | none | 8 | none | none | none | none | none | 0 | 2 | none | 1 | none | none | none | none | none | none | none | 0 | none | none | none | none | none | none | |
| Beijing Hospital, Capital Medical University北京市中西医结合医院 | none | none | none | none | none | none | none | none | none | none | none | none | 2 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 4 | none | none | none | none | none | none | none | none | 4 | none | none | none | 1 | 1 | none | none | none | none | none | none | none | none | none | |
| Beijing Huairou Hospital北京怀柔医院 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Beijing HuiLongGuan Hospital北京回龙观医院 | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Beijing Jishuitan Hospital北京积水潭医院 | none | none | none | none | none | none | none | none | none | none | 0 | 21 | none | none | 1 | 6 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 4 | none | 0 | none | none | none | 0 | none | none | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | |
| Beijing Jishuitan Hospital Guizhou Hospital北京积水潭医院贵州医院 | none | none | none | none | none | none | none | none | none | none | 1 | 2 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 2 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Beijing Jishuitan Hospital Liaocheng Hospital北京积水潭医院聊城医院 | none | none | none | none | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Beijing Lu Daopei Hospital北京道培医院 | none | none | none | none | none | none | none | none | none | none | none | 1 | none | none | 1 | none | 1 | none | 3 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Beijing Luhe Hospital首都医科大学附属北京潞河医院 | none | none | none | none | none | 7 | none | none | none | 1 | none | 0 | 0 | 2 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 3 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 0 | none | none | none | none | none | |
| Beijing Rehabilitation Hospital首都医科大学附属北京康复医院 | none | none | none | none | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Beijing Sanbo Brain Hospital北京三博脑科医院 | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Beijing Shijitan Hospital北京世纪坛医院 | none | 1 | 9 | 14 | 47 | none | 28 | 13 | 0 | none | none | 1 | none | 0 | none | none | none | none | none | 4 | 0 | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | 2 | none | none | 1 | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Beijing Stomatological Hospital首都医科大学附属北京口腔医院 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 5 | none | none | none | none | none | none | none | none | none | none | none | |
| Beijing Tiantan Hospital首都医科大学附属北京天坛医院 | none | none | none | none | 18 | none | none | 30712 open | none | none | 14 | 0 | none | 0 | none | none | none | none | none | 242 open | none | 1 | none | none | none | 342 open | none | 1 | 609 open | none | none | 172 open | none | none | 6 | 1 | none | 2 | none | 4 | 0 | none | none | 1 | none | none | none | none | 0 | none | none | none | none | none | none | none | none | 1 | none | none | none | |
| Beijing Tongren Hospital首都医科大学附属北京同仁医院 | 6 | 1 | 30 | 15 | 34 | 8 | 14 | none | 8 | 21 | none | 7 | none | 9 | 1 | 6 | 01 open | none | 11 open | 357 open | none | 0 | none | none | none | 7 | 3 | 6 | none | 3 | none | 4 | 5 | 2 | 42 open | none | none | 1 | none | none | none | none | none | none | 1 | none | 2 | none | none | none | 2 | none | none | 1 | none | 0 | none | 4 | none | none | none | |
| Beijing Tsinghua Changgung Hospital北京清华长庚医院 | none | none | 29 | none | none | 4 | none | 12 | 1 | 0 | 0 | 2 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 8 | none | none | 0 | 1 | 0 | none | 1 | none | 0 | none | none | none | 1 | 0 | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | |
| Beijing United Family Hospital北京和睦家医院 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | |
| Beijing Youan Hospital, Capital Medical University首都医科大学附属北京佑安医院 | none | none | 67 | none | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | 2 | 6 | none | none | none | none | none | none | none | none | none | 5 | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | 7 | 0 | none | none | none | none | none | none | none | none | none | |
| Beijng Anzhen Hospital | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College中国医学科学院肿瘤医院 | none | none | none | none | 9 | none | 4 | none | none | none | none | none | none | none | none | none | none | none | none | 01 open | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Capital Medical University Electric Teaching Hospital北京电力医院 | none | none | none | none | none | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Capital Medical University Sanbo Brain Hospital北京三博脑科医院 | none | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Children's Hospital, Peking Union Medical College首都医科大学附属首都儿童医学中心 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | 2 | none | none | none | none | 2 | none | none | none | none | 0 | none | none | none | 1 | none | none | none | none | none | none | none | 2 | 3 | none | none | none | none | none | none | none | |
| China-Japan Friendship Hospital中日友好医院 | none | 5 | none | 13 | 563 open | 9 | none | none | none | none | none | 2 | none | none | none | 2 | none | none | 2 | 2 | none | none | none | none | none | 6 | 0 | none | none | none | none | 262 open | none | none | 0 | 01 open | none | 19 | 0 | none | 1 | 1 | 0 | 0 | none | none | 9 | none | none | none | 1 | 0 | none | none | none | none | 0 | none | none | none | none | |
| Chinese Medicine Affiliated Shenzhen Hospital北京中医药大学深圳医院(龙岗) | none | none | none | none | none | none | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Chinese Medicine Third Affiliated Hospital北京中医药大学第三附属医院 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 1 | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Chinese PLA General Hospital中国人民解放军总医院 | 8 | 27 | 1846 open | 1406 open | 176 | 712 open | 914 open | 561 open | 3 | 2 | none | 12 | 7 | 1 | 1 | 52 open | 06 open | 11 open | 21 open | 3730 open | 0 | 1 | 1 | none | none | 122 open | 52 open | 4 | 461 open | none | none | 765 open | 9 | 11 | 0 | 0 | 2 | 3 | 1 | 20 | 2 | 3 | 1 | 6 | 0 | 1 | 171 open | 1 | none | 0 | 2 | none | none | none | none | none | 0 | 1 | none | none | none | |
| Civil Aviation General Hospital民航总医院 | none | none | none | none | none | none | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Dongfang Hospital北京中医药大学东方医院 | none | none | none | none | none | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 5 | none | none | none | 1 | none | 5 | none | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Dongzhimen Hospital北京中医药大学东直门医院 | none | none | none | none | none | none | none | none | none | none | none | 0 | none | 2 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 7 | none | none | none | none | none | 2 | none | 5 | none | none | none | none | none | 1 | 4 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Dongzhimen Hospital北京中医药大学东直门医院 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Fangshan Hospital, Beijing University of Chinese Medicine北京市房山区中医医院 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| First Affiliated Hospital of Jinzhou Medical University锦州医科大学附属第一医院 | none | 3 | none | 19 | 32 | none | 21 | 8 | none | none | none | 5 | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 0 | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | 1 | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| First Hospital of Tsinghua University北京华信医院 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 10 | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| First Integrative Hospital | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Fu Wai Hospital中国医学科学院阜外心血管病医院 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 34 | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Fu Wai Hospital中国医学科学院阜外心血管病医院 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 21 open | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Fu Wai Hospital, Peking Union Medical College中国医学科学院阜外心血管病医院 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 4 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Fuwai Hospital中国医学科学院阜外心血管病医院 | none | none | none | none | none | none | none | none | none | none | none | 1 | none | 1 | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | 2432 open | 1503 open | none | none | 14 | none | none | none | none | none | 21 open | none | none | 5 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| FuWai Hospital, Peking Union Medical College | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 4 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Fuxing Hospital首都医科大学附属复兴医院 | none | none | none | none | none | none | none | none | none | none | none | 1 | none | 2 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 0 | none | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | |
| Guang Anmen Hospital中国中医科学院广安门医院 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Guang'anmen Hospital中国中医科学院广安门医院 | none | none | none | 91 open | 321 open | 10 | 122 open | none | none | none | none | none | 1 | none | none | none | none | none | none | none | 0 | none | none | none | none | none | none | 3 | none | none | none | 20 | none | 2 | none | none | none | 1 | none | none | none | none | none | none | none | none | 5 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Medical Sciences Fuwai Hospital中国医学科学院阜外医院 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| National Cancer Center / Cancer Hospital, CAMS中国医学科学院肿瘤医院 | 331 open | 18410 open | 1033 open | 1312 open | 58725 open | 452 open | 33335 open | 101 open | none | none | none | 8 | 1 | 2 | 1 | none | none | 3 | none | 832 open | 1 | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Peking Union Medical College Fuwai Hospital | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Peking Union Medical College Hospital北京协和医院 | 3 | 41 open | 6510 open | 54 | 21313 open | 2279 open | 10610 open | 521 open | none | 0 | none | 4 | 6 | 71 open | 1 | 272 open | 1 | 161 open | 7 | 7410 open | 1 | 17 | 1 | 1 | none | 8 | 477 open | 6 | 9 | none | none | 294 open | 16 | 892 open | 3 | 27 | 0 | 18 | 14 | 44 | 31 open | 2 | 1 | 2 | 492 open | none | 5 | 1 | none | 14 | 221 open | 3 | 2 | 1 | 1 | 10 | none | none | 0 | none | none | |
| Peking University Aerospace Center Hospital | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Peking University Cancer Hospital北京大学肿瘤医院 | 2 | 826 open | 425 open | 2239 open | 16122 open | 342 open | 11614 open | none | none | none | none | 4 | 121 open | 1 | 2 | 3 | none | none | none | 834 open | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Peking University First Hospital北京大学第一医院 | none | none | 202 open | 271 open | 535 open | 283 open | 444 open | none | 0 | none | none | 41 open | 2 | 6 | 1 | 175 open | none | none | 1 | 366 open | none | 1 | 2 | none | none | 1 | 5 | 3 | none | none | none | 232 open | 5 | 71 open | 1 | 1 | 1 | 4 | none | 2 | 1 | 8 | 1 | 11 | 2 | 8 | 651 open | none | 0 | none | 0 | 1 | none | 1 | 5 | none | 1 | none | none | none | none | |
| Peking University International Hospital北大国际医院 | none | none | none | none | none | none | none | none | 1 | none | none | 0 | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 6 | none | none | none | 3 | none | none | none | none | none | none | none | none | none | none | none | 2 | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Peking University People's Hospital北京大学人民医院 | none | 2 | 241 open | 213 open | 10214 open | 31 open | 4422 open | none | none | 0 | 6 | 442 open | 102 open | none | 82 open | 195 open | 194 open | 293 open | 71 open | 146 open | none | 01 open | none | 42 open | 2 | 01 open | 121 open | 3 | none | none | none | 13 | 5 | 7 | none | 1 | none | 3 | none | none | none | none | none | none | 51 open | none | 0 | 0 | none | 2 | 7 | 0 | 0 | none | none | none | 0 | none | none | none | none | |
| Peking University Shougang Hospital北京大学首钢医院 | none | none | none | none | none | none | none | none | none | none | none | 1 | 1 | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 3 | none | none | none | none | none | 0 | none | none | none | none | none | none | 0 | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Peking University Third Hospital北京大学第三医院 | none | none | 121 open | 262 open | 514 open | 162 open | 282 open | 232 open | none | none | 6 | 7 | 2 | 0 | 0 | 7 | 0 | none | none | 313 open | 0 | 1 | none | 0 | none | 2 | 2 | none | 2 | none | none | 172 open | 5 | 41 | none | 1 | 0 | 2 | none | 522 open | 01 open | 1 | none | 1 | 0 | none | 1 | none | none | none | 0 | none | none | none | none | none | 0 | none | none | none | none | |
| Plastic Surgery Hospital中国医学科学院整形外科医院 | none | none | none | none | none | none | 20 | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Plastic Surgery Hospital, Peking Union Medical College | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| PUMC Hospital中国医学科学院北京协和医院 | none | none | none | none | none | 0 | none | none | none | none | none | 0 | 0 | none | 0 | none | none | 0 | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | 0 | none | none | none | 0 | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | none | 1 | none | none | none | none | none | |
| Sanbo Brain Hospital首都医科大学三博脑科医院 | none | none | none | none | none | none | none | 301 open | none | none | 2 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Sanbo Brain Hospital, Capital Medical University | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Second Artillery General Hospital中国人民解放军火箭军特色医学中心 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Shijitan Hospital, Captial Medical University首都医科大学附属北京世纪坛医院 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Wangjing Hospital中国中医科学院望京医院 | none | none | none | none | none | none | none | none | none | none | none | 2 | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Xiyuan Hospital中国中医科学院西苑医院 | none | none | none | none | none | none | none | none | none | none | none | none | none | 3 | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | 25 | none | none | none | none | none | 0 | none | 1 | none | none | none | none | none | none | 9 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Xuanwu Hospital首都医科大学宣武医院 | 2 | none | 15 | 5 | 262 open | 6 | 12 | 25 | none | 0 | 7 | 1 | none | 3 | none | none | 0 | none | none | 7 | 1 | none | none | 1 | none | 52 open | 2 | 161 open | 7 | none | none | 151 open | 5 | 122 open | 9 | 6 | none | none | none | 7 | none | none | none | 1 | 0 | none | 2 | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | |
| Yuquan Hospital清华大学玉泉医院 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 2 | none | none | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | |
Column labels are short names. Choose one to open that disease in Beijing.
- Oesophageal squamous cell carcinoma 6
- Osteosarcoma 1
- Gastrointestinal stromal tumour 0
- Haemophagocytic lymphohistiocytosis 2
- Beta thalassaemia 0
- IgG4-related disease 0
- Coronary heart disease 19611 open
- Congenital heart disease 805 open
- Takayasu arteritis 30
- Idiopathic pulmonary fibrosis 1
- Fabry disease 0
- Behçet disease 2
- Alport syndrome 1
- IgA nephropathy 3
- Primary biliary cholangitis 1
- Oesophageal squamous cell carcinoma 8
- Hepatocellular carcinoma 18
- Stomach cancer 12
- Lung cancer 662 open
- Pancreatic cancer 18
- Breast cancer 21
- Chordoma 2
- Osteosarcoma 6
- Gastrointestinal stromal tumour 0
- Neuroblastoma 1
- Ewing sarcoma 2
- Multiple myeloma 52
- Lymphoma 2
- Beta thalassaemia 0
- Atypical haemolytic uraemic syndrome 0
- Thrombotic thrombocytopenic purpura 0
- Coronary heart disease 342 open
- Congenital heart disease 3
- Scoliosis 40
- Takayasu arteritis 3
- Idiopathic pulmonary fibrosis 13
- Amyotrophic lateral sclerosis 1
- Behçet disease 1
- IgA nephropathy 4
- Primary biliary cholangitis 3
- Primary sclerosing cholangitis 2
- Congenital diaphragmatic hernia 1
- Familial adenomatous polyposis 0
- Hepatoblastoma 4
- Retinoblastoma 6
- Osteosarcoma 5
- Neuroblastoma 331 open
- Ewing sarcoma 4
- B-cell acute lymphoblastic leukaemia 4
- Aplastic anaemia 9
- Haemophagocytic lymphohistiocytosis 311 open
- Lymphoma 25
- Beta thalassaemia 1
- Haemophilia A 33
- Atypical haemolytic uraemic syndrome 2
- Thrombotic thrombocytopenic purpura 0
- Fanconi anaemia 1
- Neuromyelitis optica spectrum disorder 2
- Moyamoya disease 2
- Biliary atresia 15
- Coronary heart disease 6
- Congenital heart disease 24
- Scoliosis 17
- Anti-NMDA receptor encephalitis 4
- Takayasu arteritis 3
- Amyotrophic lateral sclerosis 1
- Spinal muscular atrophy 0
- Fabry disease 0
- Duchenne muscular dystrophy 1
- Behçet disease 1
- Alport syndrome 1
- IgA nephropathy 7
- Gaucher disease 0
- Hirschsprung disease 13
- Inherited epidermolysis bullosa 1
- Majeed syndrome 0
- Oesophageal squamous cell carcinoma 12
- Hepatocellular carcinoma 511 open
- Stomach cancer 457 open
- Lung cancer 38
- Pancreatic cancer 10
- Breast cancer 401 open
- Hepatoblastoma 1
- Retinoblastoma 1
- Osteosarcoma 2
- Gastrointestinal stromal tumour 2
- Neuroblastoma 47
- Ewing sarcoma 1
- Multiple myeloma 1
- Haemophagocytic lymphohistiocytosis 523 open
- Lymphoma 30
- Haemophilia A 0
- Thrombotic thrombocytopenic purpura 0
- IgG4-related disease 12
- Myasthenia gravis 1
- Wilson disease 41 open
- Biliary atresia 4
- Coronary heart disease 251 open
- Congenital heart disease 0
- Takayasu arteritis 2
- Idiopathic pulmonary fibrosis 1
- Pompe disease 1
- Behçet disease 1
- IgA nephropathy 0
- Gaucher disease 2
- Primary biliary cholangitis 121 open
- Primary sclerosing cholangitis 4
- Hirschsprung disease 0
- Hepatocellular carcinoma 151 open
- Stomach cancer 4
- Lung cancer 74
- Pancreatic cancer 10
- Breast cancer 25
- Gastrointestinal stromal tumour 0
- Neuroblastoma 1
- Multiple myeloma 2
- Lymphoma 6
- Haemophilia A 2
- Thrombotic thrombocytopenic purpura 0
- Neuromyelitis optica spectrum disorder 0
- Myasthenia gravis 11
- Moyamoya disease 41 open
- Coronary heart disease 303 open
- Congenital heart disease 3
- Anti-NMDA receptor encephalitis 0
- Takayasu arteritis 1
- Idiopathic pulmonary fibrosis 8
- Duchenne muscular dystrophy 0
- Behçet disease 2
- IgA nephropathy 1
- Inherited epidermolysis bullosa 0
- Lung cancer 18
- Glioma 30712 open
- Chordoma 14
- Osteosarcoma 0
- Neuroblastoma 0
- Lymphoma 242 open
- Haemophilia A 1
- Neuromyelitis optica spectrum disorder 342 open
- Myasthenia gravis 1
- Moyamoya disease 609 open
- Coronary heart disease 172 open
- Anti-NMDA receptor encephalitis 6
- Takayasu arteritis 1
- Idiopathic pulmonary fibrosis 2
- Amyotrophic lateral sclerosis 4
- Spinal muscular atrophy 0
- Duchenne muscular dystrophy 1
- Niemann–Pick disease type C 0
- Leber hereditary optic neuropathy 1
- Nasopharyngeal carcinoma 6
- Oesophageal squamous cell carcinoma 1
- Hepatocellular carcinoma 30
- Stomach cancer 15
- Lung cancer 34
- Pancreatic cancer 8
- Breast cancer 14
- Hepatoblastoma 8
- Retinoblastoma 21
- Osteosarcoma 7
- Neuroblastoma 9
- Ewing sarcoma 1
- Multiple myeloma 6
- B-cell acute lymphoblastic leukaemia 01 open
- Haemophagocytic lymphohistiocytosis 11 open
- Lymphoma 357 open
- Haemophilia A 0
- Neuromyelitis optica spectrum disorder 7
- IgG4-related disease 3
- Myasthenia gravis 6
- Wilson disease 3
- Coronary heart disease 4
- Congenital heart disease 5
- Scoliosis 2
- Anti-NMDA receptor encephalitis 42 open
- Idiopathic pulmonary fibrosis 1
- Behçet disease 1
- IgA nephropathy 2
- Primary biliary cholangitis 2
- Hirschsprung disease 1
- Hereditary angioedema 0
- Leber hereditary optic neuropathy 4
- Hepatocellular carcinoma 29
- Pancreatic cancer 4
- Glioma 12
- Hepatoblastoma 1
- Retinoblastoma 0
- Chordoma 0
- Osteosarcoma 2
- Congenital heart disease 8
- Takayasu arteritis 0
- Hepatic echinococcosis 1
- Idiopathic pulmonary fibrosis 0
- Amyotrophic lateral sclerosis 1
- Fabry disease 0
- Alport syndrome 1
- IgA nephropathy 0
- Primary sclerosing cholangitis 1
- Oesophageal squamous cell carcinoma 5
- Stomach cancer 13
- Lung cancer 563 open
- Pancreatic cancer 9
- Osteosarcoma 2
- Multiple myeloma 2
- Haemophagocytic lymphohistiocytosis 2
- Lymphoma 2
- Neuromyelitis optica spectrum disorder 6
- IgG4-related disease 0
- Coronary heart disease 262 open
- Anti-NMDA receptor encephalitis 0
- Takayasu arteritis 01 open
- Idiopathic pulmonary fibrosis 19
- Lymphangioleiomyomatosis 0
- Spinal muscular atrophy 1
- Fabry disease 1
- Pompe disease 0
- Duchenne muscular dystrophy 0
- IgA nephropathy 9
- Primary biliary cholangitis 1
- Primary sclerosing cholangitis 0
- Familial adenomatous polyposis 0
- Nasopharyngeal carcinoma 8
- Oesophageal squamous cell carcinoma 27
- Hepatocellular carcinoma 1846 open
- Stomach cancer 1406 open
- Lung cancer 176
- Pancreatic cancer 712 open
- Breast cancer 914 open
- Glioma 561 open
- Hepatoblastoma 3
- Retinoblastoma 2
- Osteosarcoma 12
- Gastrointestinal stromal tumour 7
- Neuroblastoma 1
- Ewing sarcoma 1
- Multiple myeloma 52 open
- B-cell acute lymphoblastic leukaemia 06 open
- Aplastic anaemia 11 open
- Haemophagocytic lymphohistiocytosis 21 open
- Lymphoma 3730 open
- Beta thalassaemia 0
- Haemophilia A 1
- Atypical haemolytic uraemic syndrome 1
- Neuromyelitis optica spectrum disorder 122 open
- IgG4-related disease 52 open
- Myasthenia gravis 4
- Moyamoya disease 461 open
- Coronary heart disease 765 open
- Congenital heart disease 9
- Scoliosis 11
- Anti-NMDA receptor encephalitis 0
- Takayasu arteritis 0
- Hepatic echinococcosis 2
- Idiopathic pulmonary fibrosis 3
- Lymphangioleiomyomatosis 1
- Amyotrophic lateral sclerosis 20
- Spinal muscular atrophy 2
- Fabry disease 3
- Pompe disease 1
- Duchenne muscular dystrophy 6
- Behçet disease 0
- Alport syndrome 1
- IgA nephropathy 171 open
- Gaucher disease 1
- Osteogenesis imperfecta 0
- Primary biliary cholangitis 2
- Familial adenomatous polyposis 0
- Leber hereditary optic neuropathy 1
- Nasopharyngeal carcinoma 331 open
- Oesophageal squamous cell carcinoma 18410 open
- Hepatocellular carcinoma 1033 open
- Stomach cancer 1312 open
- Lung cancer 58725 open
- Pancreatic cancer 452 open
- Breast cancer 33335 open
- Glioma 101 open
- Osteosarcoma 8
- Gastrointestinal stromal tumour 1
- Neuroblastoma 2
- Ewing sarcoma 1
- Aplastic anaemia 3
- Lymphoma 832 open
- Beta thalassaemia 1
- Fanconi anaemia 1
- Idiopathic pulmonary fibrosis 1
- Nasopharyngeal carcinoma 3
- Oesophageal squamous cell carcinoma 41 open
- Hepatocellular carcinoma 6510 open
- Stomach cancer 54
- Lung cancer 21313 open
- Pancreatic cancer 2279 open
- Breast cancer 10610 open
- Glioma 521 open
- Retinoblastoma 0
- Osteosarcoma 4
- Gastrointestinal stromal tumour 6
- Neuroblastoma 71 open
- Ewing sarcoma 1
- Multiple myeloma 272 open
- B-cell acute lymphoblastic leukaemia 1
- Aplastic anaemia 161 open
- Haemophagocytic lymphohistiocytosis 7
- Lymphoma 7410 open
- Beta thalassaemia 1
- Haemophilia A 17
- Atypical haemolytic uraemic syndrome 1
- Thrombotic thrombocytopenic purpura 1
- Neuromyelitis optica spectrum disorder 8
- IgG4-related disease 477 open
- Myasthenia gravis 6
- Moyamoya disease 9
- Coronary heart disease 294 open
- Congenital heart disease 16
- Scoliosis 892 open
- Anti-NMDA receptor encephalitis 3
- Takayasu arteritis 27
- Hepatic echinococcosis 0
- Idiopathic pulmonary fibrosis 18
- Lymphangioleiomyomatosis 14
- Amyotrophic lateral sclerosis 44
- Spinal muscular atrophy 31 open
- Fabry disease 2
- Pompe disease 1
- Duchenne muscular dystrophy 2
- Behçet disease 492 open
- IgA nephropathy 5
- Gaucher disease 1
- Osteogenesis imperfecta 14
- Primary biliary cholangitis 221 open
- Primary sclerosing cholangitis 3
- Congenital diaphragmatic hernia 2
- Hirschsprung disease 1
- Inherited epidermolysis bullosa 1
- Hereditary angioedema 10
- Majeed syndrome 0
- Nasopharyngeal carcinoma 2
- Oesophageal squamous cell carcinoma 826 open
- Hepatocellular carcinoma 425 open
- Stomach cancer 2239 open
- Lung cancer 16122 open
- Pancreatic cancer 342 open
- Breast cancer 11614 open
- Osteosarcoma 4
- Gastrointestinal stromal tumour 121 open
- Neuroblastoma 1
- Ewing sarcoma 2
- Multiple myeloma 3
- Lymphoma 834 open
- Anti-NMDA receptor encephalitis 0
- Hepatocellular carcinoma 202 open
- Stomach cancer 271 open
- Lung cancer 535 open
- Pancreatic cancer 283 open
- Breast cancer 444 open
- Hepatoblastoma 0
- Osteosarcoma 41 open
- Gastrointestinal stromal tumour 2
- Neuroblastoma 6
- Ewing sarcoma 1
- Multiple myeloma 175 open
- Haemophagocytic lymphohistiocytosis 1
- Lymphoma 366 open
- Haemophilia A 1
- Atypical haemolytic uraemic syndrome 2
- Neuromyelitis optica spectrum disorder 1
- IgG4-related disease 5
- Myasthenia gravis 3
- Coronary heart disease 232 open
- Congenital heart disease 5
- Scoliosis 71 open
- Anti-NMDA receptor encephalitis 1
- Takayasu arteritis 1
- Hepatic echinococcosis 1
- Idiopathic pulmonary fibrosis 4
- Amyotrophic lateral sclerosis 2
- Spinal muscular atrophy 1
- Fabry disease 8
- Pompe disease 1
- Duchenne muscular dystrophy 11
- Behçet disease 2
- Alport syndrome 8
- IgA nephropathy 651 open
- Niemann–Pick disease type C 0
- Primary biliary cholangitis 0
- Primary sclerosing cholangitis 1
- Hirschsprung disease 1
- Inherited epidermolysis bullosa 5
- Familial adenomatous polyposis 1
- Oesophageal squamous cell carcinoma 2
- Hepatocellular carcinoma 241 open
- Stomach cancer 213 open
- Lung cancer 10214 open
- Pancreatic cancer 31 open
- Breast cancer 4422 open
- Retinoblastoma 0
- Chordoma 6
- Osteosarcoma 442 open
- Gastrointestinal stromal tumour 102 open
- Ewing sarcoma 82 open
- Multiple myeloma 195 open
- B-cell acute lymphoblastic leukaemia 194 open
- Aplastic anaemia 293 open
- Haemophagocytic lymphohistiocytosis 71 open
- Lymphoma 146 open
- Haemophilia A 01 open
- Thrombotic thrombocytopenic purpura 42 open
- Fanconi anaemia 2
- Neuromyelitis optica spectrum disorder 01 open
- IgG4-related disease 121 open
- Myasthenia gravis 3
- Coronary heart disease 13
- Congenital heart disease 5
- Scoliosis 7
- Takayasu arteritis 1
- Idiopathic pulmonary fibrosis 3
- Behçet disease 51 open
- IgA nephropathy 0
- Gaucher disease 0
- Osteogenesis imperfecta 2
- Primary biliary cholangitis 7
- Primary sclerosing cholangitis 0
- Congenital diaphragmatic hernia 0
- Familial adenomatous polyposis 0
- Hepatocellular carcinoma 121 open
- Stomach cancer 262 open
- Lung cancer 514 open
- Pancreatic cancer 162 open
- Breast cancer 282 open
- Glioma 232 open
- Chordoma 6
- Osteosarcoma 7
- Gastrointestinal stromal tumour 2
- Neuroblastoma 0
- Ewing sarcoma 0
- Multiple myeloma 7
- B-cell acute lymphoblastic leukaemia 0
- Lymphoma 313 open
- Beta thalassaemia 0
- Haemophilia A 1
- Thrombotic thrombocytopenic purpura 0
- Neuromyelitis optica spectrum disorder 2
- IgG4-related disease 2
- Moyamoya disease 2
- Coronary heart disease 172 open
- Congenital heart disease 5
- Scoliosis 41
- Takayasu arteritis 1
- Hepatic echinococcosis 0
- Idiopathic pulmonary fibrosis 2
- Amyotrophic lateral sclerosis 522 open
- Spinal muscular atrophy 01 open
- Fabry disease 1
- Duchenne muscular dystrophy 1
- Behçet disease 0
- IgA nephropathy 1
- Primary biliary cholangitis 0
- Familial adenomatous polyposis 0
- Nasopharyngeal carcinoma 2
- Hepatocellular carcinoma 15
- Stomach cancer 5
- Lung cancer 262 open
- Pancreatic cancer 6
- Breast cancer 12
- Glioma 25
- Retinoblastoma 0
- Chordoma 7
- Osteosarcoma 1
- Neuroblastoma 3
- B-cell acute lymphoblastic leukaemia 0
- Lymphoma 7
- Beta thalassaemia 1
- Thrombotic thrombocytopenic purpura 1
- Neuromyelitis optica spectrum disorder 52 open
- IgG4-related disease 2
- Myasthenia gravis 161 open
- Moyamoya disease 7
- Coronary heart disease 151 open
- Congenital heart disease 5
- Scoliosis 122 open
- Anti-NMDA receptor encephalitis 9
- Takayasu arteritis 6
- Amyotrophic lateral sclerosis 7
- Duchenne muscular dystrophy 1
- Behçet disease 0
- IgA nephropathy 2
- Niemann–Pick disease type C 1
Other cities nearby
Straight-line distance from the city centre; counts are hospitals listed for breast cancer.
Counts are listed hospitals only, not every hospital in each city.
Where these numbers come from
Papers
English-language PubMed papers, 2021–2025, where the first or last author lists the hospital first. Definitions
Trials
ClinicalTrials.gov records with the hospital as lead sponsor or site, as of 8 Nov 2026. Search Beijing on ClinicalTrials.gov
Locations
Locations are shown at city centres. Check the hospital’s website for its address.